Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1161-1167
Published online before print March 31, 2005, doi: 10.1161/01.ATV.0000164310.67356.a9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/6/1161    most recent
01.ATV.0000164310.67356.a9v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaulmes, A.
Right arrow Articles by Raymondjean, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaulmes, A.
Right arrow Articles by Raymondjean, M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1161.)
© 2005 American Heart Association, Inc.


Vascular Biology

Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle Cells

Amandine Jaulmes; Brigitte Janvier; Marise Andreani; Michel Raymondjean

From UMR Physiologie et Physiopathologie, Université Pierre et Marie Curie, Paris, France.

Correspondence to Michel Raymondjean, UMR Physiologie et Physiopathologie, Université Pierre et Marie Curie, Case courrier 256, Bâtiment A, 5ème étage, 7 quai St Bernard, 75252 Paris cedex 05, France. E-mail michel.raymondjean{at}snv.jussieu.fr

Objective— The inflammation that occurs during the development of atherosclerosis is characterized by a massive release of sPLA2-IIA (group IIA secretory phospholipase A2) from vascular smooth muscle cells (VSMCs). We have investigated the autocrine function of sPLA2-IIA in rat aortic and human VSMCs.

Methods and Results— We found that the transcription of the endogenous sPLA2-IIA gene increased by adding a cell supernatant containing human sPLA2-IIA proteins. We show that this effect was independent of the sPLA2 activity using sPLA2-IIA proteins lacking enzyme activity. Transient transfections with various sPLA2-IIA rat promoter-luciferase constructs demonstrated that the C/EBP, NK-{kappa}B, and Ets transcription factors are involved in the increase in sPLA2-IIA gene transcription. We also found the M-type sPLA2 receptor mRNA in VSMCs, and we showed that the sPLA2-luciferase reporter gene was induced by the specific agonist of the sPLA2 receptor, aminophenylmannopyranoside (APMP), and that this induction was mediated by the same transcription factor-binding sites. Finally, we used a sPLA2-IIA mutant unable to bind heparan-sulfate proteoglycans to show that the binding of wild-type sPLA2-IIA to proteoglycans is essential for the induction of an autocrine loop.

Conclusions— We have thus identified new autocrine and paracrine pathways activating sPLA2-IIA gene expression in rat and human VSMCs.

A cell supernatant containing human sPLA2-IIA proteins increases the transcription of the sPLA2-IIA gene in rat and human VSMCs. This effect, independent of the sPLA2 catalytic activity, could involve a sPLA2 receptor and heparan sulfate proteoglycans binding. We thus describe a new autocrine role of sPLA2-IIA in VSMCs.


Key Words: atherosclerosis • autocrine/paracrine effects • type IIA sPLA2 • vascular smooth muscle cells




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. Ibeas, L. Fuentes, R. Martin, M. Hernandez, and M. L. Nieto
Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis
Cardiovasc Res, January 1, 2009; 81(1): 54 - 63.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. J. Cho, M. R. Seon, Y. M. Lee, J. Kim, J.-K. Kim, S. G. Kim, and J. H. Y. Park
3,3'-Diindolylmethane Suppresses the Inflammatory Response to Lipopolysaccharide in Murine Macrophages
J. Nutr., January 1, 2008; 138(1): 17 - 23.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Ravaux, C. Denoyelle, C. Monne, I. Limon, M. Raymondjean, and K. El Hadri
Inhibition of Interleukin-1{beta}-Induced Group IIA Secretory Phospholipase A2 Expression by Peroxisome Proliferator-Activated Receptors (PPARs) in Rat Vascular Smooth Muscle Cells: Cooperation between PPAR{beta} and the Proto-Oncogene BCL-6
Mol. Cell. Biol., December 1, 2007; 27(23): 8374 - 8387.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Jaulmes, S. Thierry, B. Janvier, M. Raymondjean, and V. Marechal
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1{beta}
FASEB J, August 1, 2006; 20(10): 1727 - 1729.
[Abstract] [Full Text] [PDF]